000 01859 a2200601 4500
005 20250514222521.0
264 0 _c20050707
008 200507s 0 0 eng d
022 _a1351-0088
024 7 _a10.1677/erc.1.00876
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerruti, A
245 0 0 _aIndependent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
_h[electronic resource]
260 _bEndocrine-related cancer
_cMar 2005
300 _a109-17 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlbumins
_xmetabolism
650 0 4 _aAlkaline Phosphatase
_xblood
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aBone Neoplasms
_xblood
650 0 4 _aCell Differentiation
650 0 4 _aChromogranin A
650 0 4 _aChromogranins
_xblood
650 0 4 _aHemoglobins
_xmetabolism
650 0 4 _aHumans
650 0 4 _aL-Lactate Dehydrogenase
_xblood
650 0 4 _aLiver Neoplasms
_xblood
650 0 4 _aLung Neoplasms
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aNeoplasms, Hormone-Dependent
_xblood
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatic Neoplasms
_xblood
650 0 4 _aSurvival Rate
700 1 _aMosca, A
700 1 _aTucci, M
700 1 _aTerrone, C
700 1 _aTorta, M
700 1 _aTarabuzzi, R
700 1 _aRusso, L
700 1 _aCracco, C
700 1 _aBollito, E
700 1 _aScarpa, R M
700 1 _aAngeli, A
700 1 _aDogliotti, L
773 0 _tEndocrine-related cancer
_gvol. 12
_gno. 1
_gp. 109-17
856 4 0 _uhttps://doi.org/10.1677/erc.1.00876
_zAvailable from publisher's website
999 _c15459648
_d15459648